skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
TAC Regimen (Code C63435)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: TAC Regimen

Definition: A regimen consisting of docetaxel, doxorubicin and cyclophosphamide used in the adjuvant setting for the treatment of breast cancer.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin), and cyclophosphamide.

Label: TAC Regimen

NCI Thesaurus Code: C63435 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1883257  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
TAC Regimen
TAC regimen
Taxotere-Adriamycin-Cytoxan Regimen

External Source Codes: 
PDQ Closed Trial Search ID 657046
PDQ Open Trial Search ID 657046 (check for NCI PDQ open clinical trial info)
UMLS CUI C1883257

Other Properties:
     Name Value (qualifiers indented underneath)
code C63435
DesignNote Source: NCCN Guidelines 2007
Legacy_Concept_Name TAC_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom